Until recently, for most patients, biliary-tract cancer could be managed only by supportive care, with resection possible in a few individuals. In parallel with improved surgical procedures and a multidisciplinary approach, oncological treatment has evolved and now offers options with survival benefit. The continued improvement of systemic treatment is an exciting research topic with great potential. Various chemotherapy treatments, including gemcitabine, result in better outcomes than supportive...